{
  "_id": "68024a013ccffd1c7912c7e7",
  "ipo_id": "2024_sai_life_sciences_limited_ipo",
  "__v": 0,
  "_metadata": {
    "sectionsAvailable": {
      "basicDetails": true,
      "tentativeSchedule": true,
      "lotSize": true,
      "timeline": false,
      "kpi": true,
      "financials": true,
      "promoterHolding": true,
      "objectives": false,
      "about": true,
      "subscriptionStatus": true,
      "contactDetails": true,
      "registrarDetails": true,
      "leadManagers": true,
      "listingDetails": true,
      "listingDayTrading": true,
      "faqs": true,
      "recommendationSummary": true,
      "prospectusLinks": true,
      "reservation": true,
      "anchorInvestors": true
    },
    "scrapedAt": "2025-04-18T12:16:54.753Z",
    "sourceUrl": "https://www.chittorgarh.com/ipo/sai-life-sciences-ipo/1925/"
  },
  "about": {
    "details": "<p>Incorporated in January 1999, Sai Life Sciences Limited researches, develops, and manufactures small-molecule new chemical entities. The company offers tailor-made services to biotech firms and global pharma companies.</p>\n<p>In the Financial Year 2024 and for the month ending September 30, 2024, the company provided services to over 280 innovator pharmaceutical companies, including more than 230 in that month alone. Among these clients, the company worked with 18 of the top 25 pharmaceutical companies based on their revenue in the calendar year 2023.The services were offered across countries such as the US, the UK, Europe, and Japan.</p>\n<p>The company's business development team consists of 16 experienced and qualified professionals, with six located in the US, nine in the UK and Europe, and one in Japan.</p>\n<p>The company has the following service offerings.</p>\n<ul>\n<li>Capabilities in chemistry, manufacturing, and control(“CMC”)/contract development and manufacturing organisations (“CDMO”).</li>\n<li>CRO services include integrated discovery (“Discovery”) capabilities across biology, chemistry, drug metabolism and pharmacokinetics</li>\n</ul>\n<p>As of September 30, 2024, the company had 2,353 scientific staff, with the majority of the scientific team holding advanced degrees, including 302 Ph. D.s and 1,475 master’s degrees.</p>\n<p>As of September 30, 2024, the company had 3135 employees with capabilities across the CRDMO value chain.</p>\n<p><strong>Competitive Strength:</strong></p>\n<ol>\n<li>As an integrated CRDMO, the company provide a complete platform for discovery, development, and manufacturing.</li>\n<li>CRO services include integrated discovery capabilities across biology, chemistry, and drug metabolism and pharmacokinetics.</li>\n<li>CDMO platform with a diverse mix of commercial and under-development molecules</li>\n</ol>"
  },
  "additionalTables": [
    {
      "heading": "Sai Life Sciences Limited Financial Information (Restated Consolidated)",
      "sanitizedHeading": "financials",
      "headers": [
        "Period Ended",
        "30 Sep 2024",
        "31 Mar 2024",
        "31 Mar 2023",
        "31 Mar 2022"
      ],
      "rows": [
        [
          "Assets",
          "2476.78",
          "2275.14",
          "2186.65",
          "2164.23"
        ],
        [
          "Revenue",
          "693.35",
          "1494.27",
          "1245.11",
          "897.74"
        ],
        [
          "Profit After Tax",
          "28.01",
          "82.81",
          "9.99",
          "6.23"
        ],
        [
          "Net Worth",
          "1044.75",
          "974.34",
          "887.29",
          "877.76"
        ],
        [
          "Reserves and Surplus",
          "1025.44",
          "953.99",
          "867.43",
          "859.17"
        ],
        [
          "Total Borrowing",
          "764.49",
          "710.16",
          "699.23",
          "751.32"
        ]
      ]
    },
    {
      "heading": "Sai Life Sciences Limited Stock Quote & Charts",
      "sanitizedHeading": "sai_life_sciences_stock_quote_charts",
      "headers": [
        "KPI",
        "Values"
      ],
      "rows": [
        [
          "ROE",
          "11.79%"
        ],
        [
          "ROCE",
          "15.96%"
        ],
        [
          "RoNW",
          "8.13%"
        ],
        [
          "PAT Margin",
          "5.65"
        ],
        [
          "Price to Book Value",
          "10.18"
        ]
      ]
    },
    {
      "heading": "Sai Life Sciences Limited Stock Quote & Charts",
      "sanitizedHeading": "sai_life_sciences_stock_quote_charts",
      "headers": [
        null,
        "Pre IPO",
        "Post IPO"
      ],
      "rows": [
        [
          "EPS (Rs)",
          "4.34",
          "2.69"
        ],
        [
          "P/E (x)",
          "126.42",
          "203.82"
        ]
      ]
    }
  ],
  "anchorInvestors": {
    "summary": "Sai Life Sciences IPO raises Rs 912.79 crore from anchor investors. Sai Life Sciences IPO Anchor bid date is December 10 2024. Sai Life Sciences IPO Anchor Investors list",
    "list_link": {
      "text": "Sai Life Sciences IPO Anchor Investors list",
      "url": "https://www.chittorgarh.net/reports/anchor-investor/sai_life_sciencesanchorallocationreport.pdf"
    },
    "details": {
      "ipo_date": "March 15 2025",
      "shares_offered": "16626336",
      "anchor_portion_size": "912.79"
    }
  },
  "basicDetails": {
    "ipoDate": "December 11, 2024 to December 13, 2024",
    "ipoListingDate": "Wed, Dec 18, 2024",
    "faceValue": "₹1 per share",
    "issuePrice": "₹549.00",
    "lotSize": "27 Shares",
    "issueSize": "5,54,21,123 shares (aggregating up to ₹3,042.62 Cr)",
    "freshIssue": "1,73,04,189 shares (aggregating up to ₹950.00 Cr)",
    "offerForSale": "3,81,16,934 shares of ₹1 (aggregating up to ₹2,092.62 Cr)",
    "issueType": "Bookbuilding IPO",
    "listingAt": "BSE, NSE",
    "ipoOpenDate": "Wed, Dec 11, 2024",
    "ipoCloseDate": "Fri, Dec 13, 2024",
    "initiationOfRefunds": "Tue, Dec 17, 2024",
    "creditOfSharesToDemat": "Tue, Dec 17, 2024",
    "shareHoldingPreIssue": "19,06,85,340 shares",
    "shareHoldingPreIssueAll": [
      {
        "label": "Share Holding Pre Issue",
        "value": "19,06,85,340 shares"
      },
      {
        "label": "Share Holding Pre Issue",
        "value": "40.48%"
      }
    ],
    "shareHoldingPostIssue": "20,79,89,529 shares",
    "shareHoldingPostIssueAll": [
      {
        "label": "Share Holding Post Issue",
        "value": "20,79,89,529 shares"
      },
      {
        "label": "Share Holding Post Issue",
        "value": "35.1%"
      }
    ]
  },
  "closing_date": "2024-12-12T18:30:00.000Z",
  "contactDetails": {
    "phone": "+9140 6815 6000",
    "email": "investors@sailife.com",
    "full_address": "Sai Life Sciences Limited, Plot No. DS-7 IKP Knowledge Park, Turkapally Village Shameerpet Mandal, Malkajgiri District Hyderabad-500078",
    "website": "https://www.sailife.com/"
  },
  "createdAt": "2025-04-18T12:48:01.232Z",
  "faqs": [
    {
      "question": "What is the Sai Life Sciences IPO?",
      "answer": "<div itemprop=\"text\"><p>Sai Life Sciences IPO<!-- --> is a <b>main-board<!-- --> <!-- -->IPO<!-- --> of <!-- -->55421123<!-- --> equity shares</b> of the face value of ₹<!-- -->1<!-- --> aggregating up to ₹<!-- -->3,042.62<!-- --> Crores. The issue is priced at <span>₹549 per share</span>. The minimum order quantity is <!-- -->27<!-- -->.</p><p>The <!-- -->IPO<!-- --> <b>opens on <!-- -->December 11, 2024</b>, and <b>closes on <!-- -->December 13, 2024</b>.</p><p>Kfin Technologies Limited<!-- --> is the registrar for the <!-- -->IPO<!-- -->. The shares are proposed to be listed on <!-- -->BSE, NSE<!-- -->.</p></div>"
    },
    {
      "question": "How to apply in Sai Life Sciences IPO through Zerodha?",
      "answer": "<div itemprop=\"text\"><p>Zerodha customers can apply online in <!-- -->Sai Life Sciences IPO<!-- --> using UPI as a payment gateway. Zerodha customers can apply in <!-- -->Sai Life Sciences IPO<!-- --> by login into Zerodha Console (back office) and submitting an IPO application form.</p><p><strong>Steps to apply in <!-- -->Sai Life Sciences IPO<!-- --> through Zerodha</strong></p><ol><li>Visit the Zerodha website and login to Console.</li><li>Go to Portfolio and click the IPOs link.</li><li>Go to the '<!-- -->Sai Life Sciences IPO<!-- -->' row and click the 'Bid' button.</li><li>Enter your UPI ID, Quantity, and Price.</li><li>Submit IPO application form.</li><li>Visit the UPI App (net banking or BHIM) to approve the mandate.</li></ol><p>Visit <a href=\"/broker/zerodha/ipo/18/\" title=\"Zerodha IPO Application Process Review\">Zerodha IPO Application Process Review</a> for more detail.</p></div>"
    },
    {
      "question": "When Sai Life Sciences IPO will open?",
      "answer": "<div itemprop=\"text\"><p>The Sai Life Sciences IPO opens on December 11, 2024 and closes on December 13, 2024.</p></div>"
    },
    {
      "question": "What is the lot size of Sai Life Sciences IPO?",
      "answer": "<div itemprop=\"text\"><p>Sai Life Sciences IPO<!-- --> <b>lot size is <!-- -->27</b>, and the <b>minimum amount required is <span>₹14,823</span></b>.</p></div>"
    },
    {
      "question": "How to apply for Sai Life Sciences IPO?",
      "answer": "<div itemprop=\"text\"><p>You can apply in <!-- -->Sai Life Sciences IPO<!-- --> online using either <a href=\"/article/upi-payment-option-ipo-application-explained/382/\">UPI</a> or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through <a href=\"/broker/zerodha/ipo/18/\" title=\"Zerodha IPO Review\"><b>Zerodha</b></a>, <a href=\"/broker/upstox/ipo/33/\" title=\"Upstox IPO Review\">Upstox</a>, <a href=\"/broker/5paisa/ipo/4/\" title=\"5Paisa IPO Review\">5Paisa</a>, <a href=\"/broker/edelweiss_broking/ipo/34/\" title=\"Nuvama IPO Review\">Nuvama</a>, <a href=\"/broker/hdfc-securities/ipo/6/\" title=\"HDFC Bank IPO Review\">HDFC Bank</a>, and <a href=\"/broker/sbi-capital/ipo/19/\" title=\"SBI Capital IPO Review\">SBI Bank</a>.</p></div>"
    },
    {
      "question": "When is Sai Life Sciences IPO allotment?",
      "answer": "<div itemprop=\"text\"><p>The finalization of Basis of Allotment for <!-- -->Sai Life Sciences IPO<!-- --> will be done on <!-- -->Monday, December 16, 2024<!-- -->, and the allotted shares will be credited to your demat account by <!-- -->Tuesday, December 17, 2024<!-- -->. Check the <a href=\"/ipo_allotment_status/sai-life-sciences-ipo/1925/\" title=\"Sai Life Sciences IPO Allotment Status\">Sai Life Sciences IPO<!-- --> allotment status</a>.</p></div>"
    },
    {
      "question": "When is Sai Life Sciences IPO listing date?",
      "answer": "<div itemprop=\"text\"><p>The <!-- -->Sai Life Sciences IPO<!-- --> listing date is on <b>Wednesday, December 18, 2024</b>.</p></div>"
    }
  ],
  "ipoName": "Sai Life Sciences",
  "issue_price": "₹549.00",
  "issue_price_numeric": 549,
  "issue_size": "5,54,21,123 shares (aggregating up to ₹3,042.62 Cr)",
  "issue_size_numeric": 5,
  "leadManagerReports": [
    {
      "text": "IPO Lead Manager Performance Summary",
      "url": "/report/ipo_lead_manager_performance_tracker/19/"
    },
    {
      "text": "IPO Lead Manager Performance Tracker",
      "url": "/report/ipo-lead-manager-vs-listing-gain/99/17/"
    }
  ],
  "leadManagers": [
    {
      "name": "Kotak Mahindra Capital Company Limited",
      "url": "/report/ipo-lead-manager-review/112/12/",
      "performance_link": "/report/ipo-lead-manager-vs-listing-gain/99/12/"
    },
    {
      "name": "Jefferies India Private Limited",
      "url": "/report/ipo-lead-manager-review/112/112/",
      "performance_link": "/report/ipo-lead-manager-vs-listing-gain/99/112/"
    },
    {
      "name": "Morgan Stanley India Company Pvt Ltd",
      "url": "/report/ipo-lead-manager-review/112/31/",
      "performance_link": "/report/ipo-lead-manager-vs-listing-gain/99/31/"
    },
    {
      "name": "Iifl Securities Ltd",
      "url": "/report/ipo-lead-manager-review/112/71/",
      "performance_link": "/report/ipo-lead-manager-vs-listing-gain/99/71/"
    }
  ],
  "listingDayTrading": {
    "data": {
      "final_issue_price": {
        "bse": "549.00",
        "nse": "549.00"
      },
      "open": {
        "bse": "660.00",
        "nse": "650.00"
      },
      "low": {
        "bse": "651.20",
        "nse": "650.00"
      },
      "high": {
        "bse": "787.35",
        "nse": "780.00"
      },
      "last_trade": {
        "bse": "765.30",
        "nse": "764.65"
      }
    },
    "performance_link": {
      "text": "Check IPO Performance…",
      "url": "/ipo/ipo_perf_tracker.asp"
    }
  },
  "listingDetails": {
    "pre_open_links": [
      {
        "text": "Pre-Open Session - NSE",
        "url": "https://www.nseindia.com/market-data/new-stock-exchange-listings-today"
      },
      {
        "text": "Pre-Open Session - BSE",
        "url": "https://www.bseindia.com/eqstreamer/StockTickerSplPreOpen.html"
      }
    ],
    "ipo_date": "December 18 2024",
    "bse_script_code": "544306",
    "nse_symbol": "SAILIFE",
    "isin": "INE570L01029",
    "final_issue_price": "549 per share"
  },
  "listing_date": "2024-12-17T18:30:00.000Z",
  "listing_gains": "39.40%",
  "listing_gains_numeric": 39.4,
  "logo": "https://www.chittorgarh.net/images/ipo/sai_life_sciences_logo.png",
  "logo_url": "https://www.chittorgarh.net/images/ipo/sai_life_sciences_logo.png",
  "lotSize": {
    "summary": "Investors can bid for a minimum of 27 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Retail Investors and HNI in terms of shares and amount.",
    "applications": {
      "retail_min": {
        "application": "Retail (Min)",
        "lots": "1",
        "shares": "27",
        "amount": "14823"
      },
      "retail_max": {
        "application": "Retail (Max)",
        "lots": "13",
        "shares": "351",
        "amount": "192699"
      },
      "shni_min": {
        "application": "S-HNI (Min)",
        "lots": "14",
        "shares": "378",
        "amount": "207522"
      },
      "shni_max": {
        "application": "S-HNI (Max)",
        "lots": "67",
        "shares": "1809",
        "amount": "993141"
      },
      "bhni_min": {
        "application": "B-HNI (Min)",
        "lots": "68",
        "shares": "1836",
        "amount": "1007964"
      },
      "lot_size": {
        "application": "Lot Size Calculator"
      }
    },
    "calculator_link": {
      "text": "Lot Size Calculator",
      "url": "/ipo-hni-funding-cost-calculator/sai-life-sciences-ipo/1925/"
    }
  },
  "lot_size": 27,
  "opening_date": "2024-12-10T18:30:00.000Z",
  "pageHeading": "Sai Life Sciences Limited IPO (Sai Life Sciences IPO) Detail",
  "pageTitle": "Sai Life Sciences IPO Date, Price, GMP, Review, Details",
  "promoterHolding": {
    "promoters": "The promoters of the company are Kanumuri Ranga Raju Krishnam Raju Kanumuri Kanumuri Mytrey Sai Quest Syn Private Limited Sunflower Partners Lily Partners Marigold Partners and Tulip Partners.",
    "holdings": {
      "share_holding_pre_issue": "40.48%",
      "share_holding_post_issue": "35.1%"
    },
    "note": "The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue"
  },
  "prospectusLinks": [
    {
      "text": "Sai Life Sciences IPO DRHP",
      "url": "https://www.sebi.gov.in/filings/public-issues/jul-2024/sai-life-sciences-limited-drhp_85317.html"
    },
    {
      "text": "Sai Life Sciences IPO RHP",
      "url": "https://www.sebi.gov.in/filings/public-issues/dec-2024/sai-life-sciences-limited-rhp_89347.html"
    },
    {
      "text": "Anchor Investors in Sai Life Sciences IPO",
      "url": "https://www.chittorgarh.net/reports/anchor-investor/sai_life_sciencesanchorallocationreport.pdf"
    }
  ],
  "recommendationSummary": {
    "recommendations": {
      "brokersbrokers": {
        "subscribe": "5",
        "neutral": "1",
        "avoid": "0"
      },
      "membersmembers": {
        "subscribe": "0",
        "neutral": "2",
        "avoid": "1"
      }
    },
    "links": [
      {
        "text": "Read All Reviews",
        "url": "/ipo-recommendation/sai-life-sciences-ipo/1925/"
      },
      {
        "text": "Post Your Review",
        "url": "#"
      },
      {
        "text": "Manage Reviews",
        "url": "#"
      }
    ]
  },
  "registrarDetails": {
    "name": "Kfin Technologies Limited",
    "phone": "04067162222 04079611000",
    "email": "sailifesciences.ipo@kfintech.com",
    "website": "https://kosmic.kfintech.com/ipostatus/"
  },
  "reservation": {
    "summary": "Sai Life Sciences IPO offers 55421121 shares. 11084225 (20%) to QIB 8313168 (15%) to NII 19397392 (35%) to RII and 16626336 (30%) to Anchor investors.",
    "allocation": [
      {
        "investor_category": "Anchor Investor Shares Offered",
        "shares_offered": "16626336 (30%)",
        "maximum_allottees": "NA"
      },
      {
        "investor_category": "QIB Shares Offered",
        "shares_offered": "11084225 (20%)",
        "maximum_allottees": "NA"
      },
      {
        "investor_category": "NII (HNI) Shares Offered",
        "shares_offered": "8313168 (15%)"
      },
      {
        "investor_category": "bNII > 10L",
        "shares_offered": "5542113 (10%)",
        "maximum_allottees": "14661"
      },
      {
        "investor_category": "sNII < 10L",
        "shares_offered": "2771056 (5%)",
        "maximum_allottees": "7330"
      },
      {
        "investor_category": "Retail Shares Offered",
        "shares_offered": "19397392 (35%)",
        "maximum_allottees": "718421"
      },
      {
        "investor_category": "Total Shares Offered",
        "shares_offered": "55421121 (100%)"
      }
    ]
  },
  "scraped_at": "2025-04-18T12:48:01.232Z",
  "source_url": "",
  "status": "listed",
  "subscriptionStatus": {
    "summary": "The Sai Life Sciences IPO is subscribed 10.27 times on December 13 2024 6:19:09 PM (Day 3). The public issue subscribed 1.39 times in the retail category 29.78 times in the QIB category and 4.99 times in the NII category. Check Day by Day Subscription Details (Live Status)",
    "overall": {
      "qib": {
        "category": "QIB",
        "subscription_times": "29.78",
        "shares_offered": "11084225",
        "shares_bid_for": "330125058"
      },
      "nii": {
        "category": "NII",
        "subscription_times": "4.99",
        "shares_offered": "8313168",
        "shares_bid_for": "41522058"
      },
      "bnii": {
        "category": "bNII (bids above 10L)",
        "subscription_times": "6.1",
        "shares_offered": "5542113",
        "shares_bid_for": "33813693"
      },
      "snii": {
        "category": "sNII (bids below 10L)",
        "subscription_times": "2.78",
        "shares_offered": "2771056",
        "shares_bid_for": "7708365"
      },
      "retail": {
        "category": "Retail",
        "subscription_times": "1.39",
        "shares_offered": "19397392",
        "shares_bid_for": "26912493"
      },
      "total": {
        "category": "Total",
        "subscription_times": "10.27",
        "shares_offered": "38794785",
        "shares_bid_for": "398559609"
      }
    },
    "total_applications": "646482"
  },
  "tentativeDetails": {
    "ipo_date": "5 PM on December 13 2024",
    "tentative_allotment": "Mon Dec 16 2024",
    "initiation_of_refunds": "Tue Dec 17 2024",
    "credit_of_shares_to_demat": "Tue Dec 17 2024"
  },
  "updatedAt": "2025-04-19T04:37:11.291Z",
  "updated_at": "2025-04-18T12:48:01.232Z",
  "year": 2024,
  "worst_listing_gains": "39.40%",
  "worst_listing_gains_numeric": 39.4
}